Evidence map›Paper›PMID 42079592›Full record

ReviewFrontiers in immunology2026

Nematodes immunomodulatory mechanisms and possible clinical application.

Nikodem Świderski, Mateusz Gumienny, Anna Bielecka-Wajdman

Abstract readReview
In one paragraph

Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Nikodem ŚwiderskiDepartment of Pharmacology, Medical University of Silesia, Katowice, Poland.
Mateusz GumiennyDepartment of Pharmacology, Medical University of Silesia, Katowice, Poland.
Anna Bielecka-WajdmanDepartment of Pharmacology, Medical University of Silesia, Katowice, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Helminths have evolved complex immunomodulatory mechanisms that enable chronic infection while minimizing host damage. This review summarizes recent advances in understanding nematode-derived molecules with therapeutic potential. The phosphorylcholine-modified glycoprotein ES-62 from

Indexed as

Helminth ProteinsImmunomodulationNematodaAnimalsAntigens, HelminthHumansAntigens, HelminthES-62 protein, Acanthocheilonema viteaeHelminth ProteinsAncylostoma duodenaleAnisakis pegreffiiAscaris lumbricoidesBrugia malayicystatinES-62helminth immunomodulationimmune tolerance

Identifiers

PMID42079592
PMCPMC13128378

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.